Ballicules.com

Ursodiol

ACTIGALL

What it isHydrophilic bile acid that displaces toxic bile acids; primary biliary cholangitis and cholesterol gallstones.

Why this oneIt is the only treatment that improves transplant-free survival in primary biliary cholangitis.

What limits itIt dissolves only small, non-calcified cholesterol stones, and slowly. Diarrhea; stones recur when it is stopped.

FDA-approved for

Off-label

FDA label

FDA dosingPopulationStartTargetMax
Radiolucent gallbladder stone dissolutionAdults8–10 mg/kg/day in 2–3 divided doses8–10 mg/kg/day10 mg/kg/day
Gallstone prevention during rapid weight lossAdults300 mg BID600 mg/day600 mg/day

Renal Undefined

Hepatic Undefined

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy Animal studies show no fetal harm at therapeutic multiples; not recommended during pregnancy

Lactation Undefined

NO BOXED WARNINGS

Principal riskDiarrhea

Cost, est. cash$5–$150/month

Generic entry2000

Classes and tags

Clinical profile

Therapeutic safety burden1 / 4
Overdose danger1 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk1 / 4

Legacy pregnancy categoryUnknown / historical label unavailable

Defining liabilityGenerally tolerated at therapeutic doses; clinically important risks are agent-specific and increase with interactions or organ impairment.

Mechanism of action: Ursodiol ballicule

Ursodiol ballicule: receptor binding, kinetics and half-life diagram

Open Ursodiol in the interactive console ↗

Memory aids: mascots and interaction avatars

Ursodiol ACTIGALL mascot mnemonic cartoon
“Urso Active against gallstones”

Open Ursodiol in the interactive console ↗